In a crisis, how do you lead an early-stage company? How do you manage runway and keep morale up, continuing to deliver important work necessary to advance? Two experienced serial entrepreneurs, and the investors who backed them, will get together to share their wisdom. Matt Likens, now CEO of GT Medical, led Ulthera through the 2008 crisis to acquisition six years later. Adam Berman, who now leads Alleviant, launched TVA Medical in 2008 and took it to acquisition in 2018. Justin Klein of Vensana Capital invested in Ulthera under Matt; James Eadie of Santé Ventures invested in TVA under Adam. Join us on Wednesday, June 24 to learn from their past and current experiences.